NEWS & VIEWS

Global private equity and venture capital news and research

North America

27 November 2012

Canadian drug company MethylGene seals C26.1m private placement

Toronto-listed drug development company MethylGene has raised C$26.1m through a private placement with participants including a number of private equity investors.

26 November 2012

Riverstone close to breaking $6bn mark for latest energy fundp

Energy-focused private equity giant Riverstone is preparing to break through its $6bn target for its latest buyout fund thanks to a strong take-up from investors, AltAssets has learned.

26 November 2012

Apollo seals $2.5bn deal for McGraw-Hill Education business

US buyout firm Apollo Global Management has agreed to buy the education unit of McGraw-Hill Companies for $2.5bn.

26 November 2012

General Catalyst provides seed capital for software start-up ownCloud

US and Germany-based enterprise data company OwnCloud has closed a second seed round, led by existing investor General Catalyst Partners.

26 November 2012

Saudi investor Kingdom Holding buys Four Seasons Hotel Toronto for C$200m

Saudi investment group Kingdom Holding Company has acquired the newly opened Four Seasons hotel in Toronto for C$200m.

26 November 2012

Morgan Stanley launches small business loan fund

Financial services firm Morgan Stanley has launched a Small Business Loan Fund to support commercial expansion and create jobs in US communities battling economic decline.

26 November 2012

Onex to acquire US insurance brokerage USI for $2.3bn

Toronto-listed investment firm Onex Corporation has agreed to acquire US insurance brokerage USI for $2.3bn.

26 November 2012

Early stage VC Greycroft Partners raises $175m for third fund

JP Morgan, BlackRock Private Equity Partners, Fairview Capital, Invesco Private Capital,Hall Capital, Hamilton Lane, Greenspring Associates, Cambridge Associates

26 November 2012

Venture-backed anti-epilepsy drug developer planning $67m share salep

brain_lrg Venture capital-backed nervous system disease treatment developer Supernus Pharmaceuticals is planning to raise more than $67m by selling six million shares of common stock.

26 November 2012

Venture-backed SolarCity could list in 2012

Venture-backed residential photovoltaic installer SolarCity is now believed to be lining up its $200m initial public offering to take place before the end of the year.

Page 663 of 1,308« First...102030...661662663664665...670680690...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015